Get to know IASLC’s new Chief Science Officer and learn more about the role she and her team will play in conquering thoracic cancers in the 21st century. Read more
The IASLC seeks the lung cancer community’s input to assess the use of molecular testing—and barriers to its implementation—worldwide. Read more
Drs. Umberto Malapelle, Jarushka Naidoo, Isabelle Opitz, and Noemí Reguart will lead WCLC when it returns to Barcelona September 6-9, 2025. Read more
Projects—including a team science grant, an expanded IASLC Academy, and an international biomarker survey—aim to help the association meet the needs of the global lung cancer community, IASLC leaders say. Read more
The 2024 World Conference on Lung Cancer may still be months away, but with deadlines approaching, now is the time to submit scientific abstracts and applications for the JTO manuscript reviewer workshop. Read more
Research teams with integrated projects focused on curing oncogene-driven lung cancers could receive up to $2.5 million over 4 years. Read more
As the IASLC celebrates its 50th year, the association’s journal moves to online only and the American Cancer Society recommends expanding screening eligibility. Read more
The initiatives include a $2.5 million, 4-year research grant and projects to improve lung cancer biomarker testing uptake around the world. Read more
The association recommends collecting data on tobacco use status to advance knowledge on the impacts of tobacco smoke in the context of cancer clinical trials. Read more
Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team. Read more